Table 2 Participants’ information
From: Framing protocol optimization in oncological Patlak parametric imaging with uKinetics
Index | Gender | Age | Weight (kg) | Dose | Diagnosis |
|---|---|---|---|---|---|
1 | Male | 59 | 59 | 4.8Â mCi (176.9Â MBq) | Lung cancer |
2 | Male | 55 | 59 | 4.4Â mCi (161.8Â MBq) | Lung cancer |
3 | Male | 63 | 64 | 5.0Â mCi (185.9Â MBq) | Lung cancer |
4 | Male | 68 | 61 | 4.8Â mCi (177.2Â MBq) | Lung cancer |
5 | Female | 56 | 60 | 7.6Â mCi (281.2Â MBq) | Cholangiocarcinoma |
6 | Female | 38 | 62 | 6.8Â mCi (251.6Â MBq) | Hysteromyoma |
7 | Female | 66 | 70 | 8.1Â mCi (300.1Â MBq) | Liver cancer |
8 | Male | 63 | 57 | 6.0Â mCi (222.3Â MBq) | Liver cancer |
9 | Male | 54 | 69 | 5.5Â mCi (202.2Â MBq) | Lung cancer |
10 | Male | 64 | 58 | 6.1Â mCi (224.5Â MBq) | Lung cancer |